Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Receivables (2023 - 2025)

Historic Receivables for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $960000.0.

  • Metagenomi's Receivables rose 6298.81% to $960000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $960000.0, marking a year-over-year increase of 6298.81%. This contributed to the annual value of $1.3 million for FY2024, which is 4871.48% down from last year.
  • Latest data reveals that Metagenomi reported Receivables of $960000.0 as of Q3 2025, which was up 6298.81% from $873000.0 recorded in Q2 2025.
  • Metagenomi's 5-year Receivables high stood at $2.5 million for Q4 2023, and its period low was $589000.0 during Q3 2024.
  • Over the past 3 years, Metagenomi's median Receivables value was $1.1 million (recorded in 2024), while the average stood at $1.3 million.
  • Within the past 5 years, the most significant YoY rise in Metagenomi's Receivables was 6298.81% (2025), while the steepest drop was 5677.23% (2025).
  • Metagenomi's Receivables (Quarter) stood at $2.5 million in 2023, then tumbled by 48.71% to $1.3 million in 2024, then decreased by 23.63% to $960000.0 in 2025.
  • Its Receivables was $960000.0 in Q3 2025, compared to $873000.0 in Q2 2025 and $900000.0 in Q1 2025.